CLINICAL_TRIALS
trial_result
· 2015-07-13
Clinical Trial Update: Duragen Versus Duraguard in Chiari Surgery [Phase 3]
Summary
A Phase 3 trial comparing Duragen versus Duraguard as dural substitutes in Chiari malformation surgery, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Illinois at Chicago | Conditions: Chiari Malformation | Phase 3 | Status: COMPLETED | Results posted: 2015-07-13